Overall rank by patents
#24,893
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 9 technology areas, active 2024–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H02K (DYNAMO-ELECTRIC MACHINES).
The verdict
Nidec holds 11 US patents across 9 technology areas, rank #24,893 of 50,000 tracked assignees.
Nidec PSA Emotors has been granted 11 US utility patents between 2024 and 2025, placing Nidec PSA Emotors at rank #24,893 across all assignees tracked by PlainPatent. This portfolio spans 9 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.6 claims per patent with primary concentration in H02K (DYNAMO-ELECTRIC MACHINES). As a Foreign Corporation, Nidec PSA Emotors is one of the more focused assignees in the PatentsView dataset. By volume, Nidec sits between Newblue, Inc. (11 patents, rank #24,889) and Norgen Biotek Corp. (11 patents, rank #24,897) - the closest US assignees by grant volume. The composite Innovation Score of 48.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2024 through 2025, with 11 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Nidec PSA Emotors's 15.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 9 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Nidec PSA Emotors against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
NewBlue, Inc.
11 patents
Nexus Medical, LLC
11 patents
Nexxspan Healthcare, LLC
11 patents
NiPPharma Co., Ltd.
11 patents
Nikkeikin Aluminium Core Technology Company, Ltd.
11 patents
Ningbo Dongchuan Swimming Pool Equipment Co., Inc.
11 patents
Ningbo Meiying Electronic Technology Co., Ltd.
11 patents
Norgen Biotek Corp.
11 patents
Nidec PSA Emotors
11 patents
What this shows Nidec holds 11 patents at rank #24,893, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Nidec's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
49 Top 16% higher than 84% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2024 | 7 | 63.6% |
| 2025 | 4 | 36.4% |
Top 9 of 9 technology areas
Overall rank by patents
#24,893
Across all tracked assignees
48.5 out of 100
How to use this portfolio
Nidec's 11 grants land it in the top 16% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.